Free Trial

MKDWELL Tech (MKDW) Competitors

$1.21
+0.09 (+8.04%)
(As of 09/18/2024 ET)

MKDW vs. BYN, NVNI, SLXN, DHAC, VSEE, DMAQ, BENF, ABVE, CTOR, and WENA

Should you be buying MKDWELL Tech stock or one of its competitors? The main competitors of MKDWELL Tech include Banyan Acquisition (BYN), Nvni Group (NVNI), Silexion Therapeutics (SLXN), Digital Health Acquisition (DHAC), Vsee Health (VSEE), Deep Medicine Acquisition (DMAQ), Beneficient (BENF), Above Food Ingredients (ABVE), Citius Oncology (CTOR), and ANEW Medical (WENA). These companies are all part of the "holding & other investment offices" industry.

MKDWELL Tech vs.

MKDWELL Tech (NASDAQ:MKDW) and Banyan Acquisition (NYSE:BYN) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

In the previous week, MKDWELL Tech's average media sentiment score of 1.89 beat Banyan Acquisition's score of 0.00 indicating that MKDWELL Tech is being referred to more favorably in the media.

Company Overall Sentiment
MKDWELL Tech Very Positive
Banyan Acquisition Neutral

13.4% of Banyan Acquisition shares are held by institutional investors. 22.8% of Banyan Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
MKDWELL TechN/A N/A N/A
Banyan Acquisition N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MKDWELL Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Banyan Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MKDWELL Tech$3.67M1.27N/AN/AN/A
Banyan AcquisitionN/AN/AN/AN/AN/A

MKDWELL Tech has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, Banyan Acquisition has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500.

MKDWELL Tech and Banyan Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
MKDWELL TechN/AN/A
Banyan AcquisitionN/AN/A

Summary

MKDWELL Tech beats Banyan Acquisition on 3 of the 5 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MKDW vs. The Competition

MetricMKDWELL TechHolding Offices IndustryComputer SectorNASDAQ Exchange
Market Cap$4.65M$414.09M$21.22B$8.25B
Dividend YieldN/A7.58%2.76%4.08%
P/E RatioN/A12.14268.1418.66
Price / Sales1.276.97574.6470.57
Price / CashN/A67.4130.4231.82
Price / BookN/A86.356.774.52
Net IncomeN/A$29.54M$636.74M$224.32M
7 Day Performance37.94%0.65%1.76%4.99%
1 Month PerformanceN/A-1.10%2.11%8.35%
1 Year PerformanceN/A-2.82%17.42%11.76%

MKDWELL Tech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BYN
Banyan Acquisition
0 of 5 stars
0.00 / 5 stars
$1.23
-5.4%
N/A-89.1%$13.83MN/A0.00N/AGap Up
NVNI
Nvni Group
3.485 of 5 stars
3.49 / 5 stars
$1.00
-4.8%
$5.00
+400.0%
N/A$10.05MN/A0.00N/AUpcoming Earnings
Positive News
SLXN
Silexion Therapeutics
0 of 5 stars
0.00 / 5 stars
$1.01
-8.2%
N/AN/A$9.87MN/A0.00N/APositive News
DHAC
Digital Health Acquisition
0 of 5 stars
0.00 / 5 stars
$1.60
flat
N/AN/A$5.77MN/A0.002,021
VSEE
Vsee Health
0 of 5 stars
0.00 / 5 stars
$1.60
flat
N/AN/A$5.77M$6.38M0.00N/AGap Up
DMAQ
Deep Medicine Acquisition
0 of 5 stars
0.00 / 5 stars
$1.26
+7.7%
N/A-89.2%$5.49MN/A0.0093Gap Up
BENF
Beneficient
1.4179 of 5 stars
1.42 / 5 stars
$1.27
-1.6%
N/A-99.4%$5.40MN/A0.0080Gap Down
ABVE
Above Food Ingredients
0 of 5 stars
0.00 / 5 stars
$0.63
flat
N/AN/A$5.07MN/A0.00N/APositive News
CTOR
Citius Oncology
0 of 5 stars
0.00 / 5 stars
$1.63
-0.6%
N/AN/A$3.86MN/A0.00N/APositive News
Gap Down
WENA
ANEW Medical
0 of 5 stars
0.00 / 5 stars
$0.73
-1.4%
N/AN/A$3.77MN/A0.00N/ANews Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:MKDW) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners